Contract facts
UnrestrictedNo full NAICS 334516 intel page yet. Browse NAICS intelligence
EXERCISING OPTION YEAR 3: STATSTRIP GLUCOSE STRIPS is a federal Unrestricted award for 261-Network Contract Office 21 (36C261) held by Nova Biomedical Corp. Estimated value $114K ($32K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: RENO NV. Related solicitation 36C26123Q0020.
EXERCISING OPTION YEAR 3: STATSTRIP GLUCOSE STRIPS
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (3 days remaining). Agencies typically plan 12–18 months ahead — at 0.1 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C26123P0034? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNova Biomedical Corp — $2.5M obligated across 67 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26123P0034?
36C26123P0034 (Exercising OPTION YEAR 3: statstrip glucose) is a 261-Network Contract Office 21 (36C261) award with a potential value of $114K, currently held by Nova Biomedical Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C261-23-P-0034?
36C261-23-P-0034 is the dashed form of PIID 36C26123P0034 (Exercising OPTION YEAR 3: statstrip glucose), held by Nova Biomedical Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26123P0034?
261-Network Contract Office 21 (36C261) awarded 36C26123P0034 to Nova Biomedical Corp (potential $114K).
Who is the incumbent on 36C26123P0034?
Nova Biomedical Corp is the incumbent with $2.5M across 67 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Nova Biomedical Corp’s 36C26123P0034 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C26123P0034? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.